Monopar Therapeutics CEO receives 9,801 vested shares
The reported post-transaction position included 83,602 restricted stock units and 62,815 common shares held by the Chandler D. Robinson Irrevocable Trust.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Monopar Therapeutics Chief Executive Officer Chandler Robinson reported 9,801 restricted stock units surrendered for 9,801 common shares upon vesting and settlement on September 30, 2026. The issuer withheld 4,344 shares at $79.67 per share for withholding taxes. His reported post-transaction balance was 83,602 restricted stock units; the filing also lists 62,815 common shares held by the Chandler D. Robinson Irrevocable Trust. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F4, F5, F6 | 9,801 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 9,801 | -- | -- |
| Tax Withholding | Common Stock F2 | 4,344 | $79.67 | $346K |
| holding | Common Stock F3 | -- | -- | -- |
Footnotes (6)
- F1. Represents shares acquired on vesting and settlement of restricted stock units.
- F2. Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- F3. Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
- F4. On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths (4,225 shares) on June 30, 2023, and 3/48ths (2,113 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- F5. On March 4, 2025, the reporting person was granted 79,899 restricted stock units of which 6,002 shares vested immediately as of the grant date. The remaining 73,897 restricted stock units vest 6/48ths (9,237 shares) on June 30, 2025, and 3/48ths (4,619 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- F6. On December 2, 2025, the reporting person was granted 49,133 restricted stock units, vesting 6/48ths (6,142) on June 30, 2026, and 3/48ths (3,071 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
Key Figures
Key Terms
restricted stock units financial
withholding tax financial
contingent right technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the vesting schedule for Chandler Robinson’s MNPR restricted stock units?
AI-generated analysis. How Rhea-AI works. Not financial advice.